Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending ZEPP Q3 2025 Earnings Narrowed Loss Amid Mixed Operational Signals USBC Q1 2025 Earnings EPS Beats Estimates Despite Loss Stock Declines 513 BNT Q4 2024 Earnings Slight Profit Amid Quiet Quarter Theravance Biopharma Inc TBPH Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise PCRX Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Performance